Continuous ambulatory peritoneal dialysis (CAPD) peritonitis treatment recommendations: 1989 update. The Ad Hoc Advisory Committee on Peritonitis Management.
In conclusion, the recommendations provided in this document represent a distillation of various experiences, as well as data obtained from published studies. It is hoped that this compilation will provide a basis upon which future developments and advances can be made in the therapeutic approach to CAPD associated peritonitis. Paramount among these will be the development of rapid and accurate diagnostic techniques and efficacious antibiotic regimens using precisely derived dosing recommendations that minimize toxicity. Insights into catheter management should be developed, particularly as they pertain to exit and tunnel infections. The optimal interval before catheter reinsertion can be safely performed must be defined. Lastly, improvement in catheter design and materials should be sought.
D000900:Anti-Bacterial Agents; D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D002408:Catheters, Indwelling; D002985:Clinical Protocols; D003663:Decision Trees; D015314:Dialysis Solutions; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D008826:Microbial Sensitivity Tests; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D013997:Time Factors
D000900:Anti-Bacterial Agents; D015314:Dialysis Solutions